AAM
BOLD

Alpine Associates Management’s Audentes Therapeutics, Inc BOLD Stock Holding History

Alpine Associates Management’s Portfolio BOLD Stock Details BOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,456,000
Closed -$87.1M – 66
2019
Q4 		$87.1M Buy
+1,456,000
New +$54.6M 2.77% 16

Alpine Associates Management's BOLD Position: Q1 2020 in Review

Alpine Associates Management sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 1,456,000 shares — an estimated $87.1M sold.

Alpine Associates Management first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $87.1M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

  • Alpine Associates Management reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
  • Alpine Associates Management sold 1,456,000 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $87.1M.
  • Alpine Associates Management first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
  • Alpine Associates Management's Audentes Therapeutics, Inc position peaked at $87.1M in Q4 2019.
  • 0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Alpine Associates Management's 13F filing for Q1 2020, filed 12 May 2020.